Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.365 USD | -0.80% | +6.46% | -20.64% |
Mar. 27 | North American Morning Briefing : Stocks Edge -2- | DJ |
Mar. 25 | Marker Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 8
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immunotherapies and Innovative Peptide-Based Vaccines
100.0
%
| 9 | 100.0 % | 3 | 100.0 % | -63.26% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 9 | 100.0 % | 3 | 100.0 % | -63.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Juan F. Vera
CEO | Chief Executive Officer | 44 | 18-10-16 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 19-10-31 |
Chief Tech/Sci/R&D Officer | 51 | 18-10-22 | |
Chief Administrative Officer | - | 15-08-31 | |
John Wilson
BRD | Director/Board Member | 64 | - |
Edmund Cheung
HRO | Human Resources Officer | - | 20-12-31 |
Nadia Agopyan
LAW | General Counsel | 62 | 19-08-14 |
General Counsel | 67 | 18-10-22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 18-10-16 | |
Steven Elms
BRD | Director/Board Member | 60 | 19-08-05 |
Katharine Knobil
BRD | Director/Board Member | 60 | 21-12-07 |
John Wilson
BRD | Director/Board Member | 64 | - |
Juan F. Vera
CEO | Chief Executive Officer | 44 | 18-10-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,902,897 | 7,819,659 ( 87.83 %) | 0 | 87.83 % |
Company contact information
Marker Therapeutics, Inc.
4551 Kennedy Commerce Drive
77032, Houston
+713 400 6400
http://www.markertherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
-20.64% | 38.86M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.58% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- MRKR Stock
- Company Marker Therapeutics, Inc.